XOMA Stock Summary and Trading Ideas (Xoma Royalty | NASDAQ:XOMA)

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

Xoma Royalty trades on the NASDAQ stock market under the symbol XOMA.

As of June 4, 2026, XOMA stock price climbed to $42.40 with 133,394 million shares trading.

XOMA has a beta of 1.53, meaning it tends to be more sensitive to market movements. XOMA has a correlation of 0.15 to the broad based SPY ETF.

XOMA has a market cap of $531.74 million. This is considered a Small Cap stock.

Last quarter Xoma Royalty reported $12 million in Revenue and $.17 earnings per share. This fell short of revenue expectation by $-2 million and met earnings estimates .

In the last 3 years, XOMA traded as high as $42.81 and as low as $13.48.

The top ETF exchange traded funds that XOMA belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

XOMA has outperformed the market in the last year with a return of +73.8%, while the SPY ETF gained +28.2%. In the last 3 month period, XOMA beat the market returning +66.0%, while SPY returned +11.5%. However, in the most recent 2 weeks XOMA has underperformed the stock market by returning +1.0%, while SPY returned +2.1%.

XOMA support price is $41.44 and resistance is $41.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XOMA shares will trade within this expected range on the day.